Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study Bisecco AlvinoFornasiero AriannaAntonio Gallo Original Communication Open access 04 August 2021 Pages: 1610 - 1617
NMDA-receptor encephalitis in Denmark from 2009 to 2019: a national cohort study Mette Scheller NissenMaren Synnøve ØrvikMorten Blaabjerg Original Communication 05 August 2021 Pages: 1618 - 1630
Role of the nigrosome 1 absence as a biomarker in amyotrophic lateral sclerosis María Isabel Moreno-GambínJosé I. TemblJuan F. Vázquez-Costa Original Communication Open access 11 August 2021 Pages: 1631 - 1640
Comparative analysis of clinical and imaging data between patients with myelin oligodendrocyte glycoprotein antibody disease and patients with aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder Haojie XieYingzhe ShaoYanjie Jia Original Communication 12 August 2021 Pages: 1641 - 1650
Efficacy and safety of N-acetyl-l-leucine in Niemann–Pick disease type C Tatiana Bremova-ErtlJens ClaassenSusanne A. Schneider Original Communication Open access 13 August 2021 Pages: 1651 - 1662
Smoking, obesity, and disability worsening in PPMS: an analysis of the INFORMS original trial dataset Marcus W. KochJop MostertGary Cutter Original Communication 15 August 2021 Pages: 1663 - 1669
Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis Massimo FilippiRomano DanesiMaria Trojano Short Commentary Open access 09 October 2021 Pages: 1670 - 1677
Progressive multifocal leukoencephalopathy and sphingosine 1-phosphate receptor modulators used in multiple sclerosis: an updated review of literature Shitiz SriwastavaDurgesh ChaudharyRobert P. Lisak Short Commentary 20 November 2021 Pages: 1678 - 1687
Natalizumab-induced pneumonitis Stefania KaniniaAnthony J. EdeyClaire M. Rice Letter to the Editors 22 September 2021 Pages: 1688 - 1690
A man with sensation of cold water running down the face Qianyan LiuLu ChenLixia Pei Letter to the Editors 24 September 2021 Pages: 1691 - 1694
Susac’s syndrome as an autoimmune complication of alemtuzumab-associated immune reconstitution Amir AhmedZi Qi KokSarah J. Crisp Letter to the Editors 29 September 2021 Pages: 1695 - 1697
Hyperactive and cross-coupled head impulse signs in recurrent strokes: clinical signs of global cerebellar dysfunction Kitae KimHyo-Jung KimJi-Soo Kim Letter to the Editors 05 October 2021 Pages: 1698 - 1700
How to diagnose and manage neurological toxicities of immune checkpoint inhibitors: an update Alberto VogrigSergio Muñiz-CastrilloBastien Joubert Neurological Update 27 October 2021 Pages: 1701 - 1714
Imaging selection for reperfusion therapy in acute ischemic stroke beyond the conventional time window Lauranne ScheldemanAnke WoutersRobin Lemmens Neurological Update 31 October 2021 Pages: 1715 - 1723
Anticoagulation in intracranial haemorrhage with atrial fibrillation J. E. ErskineT. A. T. Hughes Journal club 11 February 2022 Pages: 1724 - 1726
Pioneers in neurology: Charles Miller Fisher (1913–2012) Konrad KubickiAndrzej Grzybowski Pioneers in Neurology Open access 22 September 2021 Pages: 1727 - 1729